Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α

WuXi AppTec scientists recently contributed to a research article in the Journal of Medicinal Chemistry describing the optimization of a piperidine series of small molecules as novel allosteric activators of PKG1α (a compelling drug target for treatment of cardiovascular diseases).  This study reveals a mechanism of action for these compounds consistent with cGMP-induced activation, including antiproliferative effects in human pulmonary arterial smooth muscle cells.

https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c02109

Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α
← Return to Resources

Related Content

Introduction In recognition of International Women's Day, we spotlight women's health—a continuously evolving global healthcare issue. The year 2025 marks...

VIEW RESOURCE

Introduction: Women spend about one-third of their lives in menopause or post-menopause, a period that marks the gradual decline of...

VIEW RESOURCE
← View all Cardiovascular & Metabolic Diseases Resources
× peptide, amino acid

Contact An Expert Today!